Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Arch. argent. pediatr ; 116(6): 769-772, dic. 2018. ilus, tab
Article in Spanish | LILACS, BINACIS | ID: biblio-973695

ABSTRACT

La sepsis es la principal causa de mortalidad neonatal. La forma precoz, habitualmente, está relacionada con la colonización recto-vaginal u otros factores de riesgo materno. En la forma tardía, es difícil establecer su origen; por lo general, es nosocomial o de la comunidad. El Streptococcus agalactiae (Streptococcus beta-hemolítico del grupo B) es el germen implicado con más frecuencia en la sepsis neonatal en países desarrollados. La forma tardía, generalmente, se presenta con septicemia y meningitis, y, en ocasiones, pueden detectarse infecciones osteoarticulares o de piel y tejidos blandos. El síndrome celulitis-adenitis en la región cervical, forma poco frecuente de presentación, es causado por Staphylococcus aureus y, ocasionalmente, por Streptococcus agalactiae. Se reportan 2 casos de sepsis neonatal tardía con clínica de celulitis-adenitis cervical causados por Streptococcus beta-hemolítico del grupo B, con una evolución satisfactoria con terapia antibiótica de amplio espectro.


Septicemia is the main cause of neonatal mortality. The early-onset neonatal sepsis is usually related to maternal factor risks including recto-vaginal colonization. In the late-onset neonatal septicemia it is more difficult to establish the etiology because the majority of the cases are nosocomial or community related. The Streptococcus agalactiae (beta-hemolytic Streptococcus) is the most frequent germ associated with neonatal sepsis in developed countries. The late-onset form usually occurs with septic symptoms and meningitis and, in a few cases, with osteoarticular, skin and soft tissue infection. Adenitis-cellulitis syndrome is rarely seen, and its main cause is Staphylococcus aureus, followed by Streptococcus agalactiae. We report two cases of group B Streptococcus late-onset neonatal septicemia, both of them with adenitis-cellulitis syndrome. Patients recovered uneventfully after an adequate antibiotic therapy.


Subject(s)
Humans , Male , Infant , Streptococcal Infections/diagnosis , Cellulitis/diagnosis , Neonatal Sepsis/diagnosis , Lymphadenitis/diagnosis , Streptococcal Infections/microbiology , Streptococcal Infections/drug therapy , Streptococcus agalactiae/isolation & purification , Syndrome , Cellulitis/microbiology , Cellulitis/drug therapy , Neonatal Sepsis/microbiology , Neonatal Sepsis/drug therapy , Lymphadenitis/microbiology , Lymphadenitis/drug therapy , Anti-Bacterial Agents/administration & dosage
2.
Einstein (Säo Paulo) ; 13(3): 426-429, July-Sep. 2015. graf
Article in English | LILACS | ID: lil-761944

ABSTRACT

Cervical adenitis >1.5cm in diameter is the less frequently observed criteria in patients with Kawasaki disease and it is usually found in association with other symptoms during the acute phase. Moreover, the finding of fever and lymphadenitis with intense local signs of inflammation and phlegmon is rarely seen as the initial manifestation of Kawasaki disease. We report the case of a 7-year-old boy who had cervical lymphadenitis with adjacent cellulitis and phlegmon mimicking bacterial adenitis as the first presentation of Kawasaki disease. The patient had fever, cervical lymphadenitis with adjacent cellulitis, and severe headache. Cefadroxil was prescribed based on the clinical diagnosis of bacterial adenitis. Because he remained febrile and phlogistic signs worsened, after 1 day of hospitalization, antibiotics were administrated intravenously (ceftriaxone and oxacillin). The computed tomography of the neck showed primary infectious/inflammatory process. On the fourth day, the patient had dry and scaly lips, and treatment with oxacillin was replaced by clindamycin because the patient was still febrile. On the ninth day, he presented non-exudative bilateral conjunctival injection. On the tenth day of febrile disease, a rash appeared on his trunk, hands and feet. Patient’s symptoms resolved after intravenous administration of immunoglobulin (2g/kg/dose), and he was discharged 2 days later. On the 14th day, the patient had lamellar desquamation of fingers. Kawasaki disease should be considered as a differential diagnosis in children with febrile cervical lymphadenitis unresponsive to empiric antibiotics even if they have adjacent cellulitis and phlegmon.


Adenite cervical >1,5cm é o critério menos frequentemente observado em pacientes com doença de Kawasaki e manifesta-se habitualmente em associação com os demais sintomas da fase aguda. Entretanto, linfadenite febril isolada com intensos sinais flogísticos e flegmão é raramente observada como primeira manifestação da doença de Kawasaki. Assim, relatou-se aqui um caso de uma criança que apresentou linfadenite cervical com celulite adjacente e flegmão mimetizando adenite bacteriana como primeira manifestação da doença de Kawasaki. Paciente previamente hígido, 7 anos, masculino, iniciou quadro de febre, adenite cervical com celulite adjacente e cefaleia intensa, sendo prescrita cefadroxila devido ao diagnóstico clínico de linfadenite bacteriana. Por se manter febril e com piora dos sinais flogísticos, após 1 dia foi internado para receber antibioticoterapia endovenosa (oxacilina e ceftriaxona). Tomografia computadorizada da região cervical mostrou processo infeccioso/inflamatório primário. No quarto dia, apresentou lábios ressecados e descamativos, sendo a oxacilina substituída por clindamicina devido à persistência da febre e sinais flogísticos. No nono dia, iniciou hiperemia ocular não exsudativa. No décimo dia de febre, apresentou exantema em tronco, membros, mãos e pés. Recebeu gamaglobulina endovenosa (2g/kg/dose), evoluiu com resolução dos sintomas e, após 2 dias, recebeu alta hospitalar. No 14odia, apresentou descamação lamelar dos dedos das mãos. Portanto, doença de Kawasaki deve ser considerada no diagnóstico diferencial das linfadenites cervicais febris na infância não responsivas à antibioticoterapia empírica, mesmo que esteja presentes celulite adjacente e flegmão.


Subject(s)
Child , Humans , Male , Cellulitis/diagnosis , Mucocutaneous Lymph Node Syndrome/diagnosis , Cellulitis/complications , Diagnosis, Differential , Fever/complications , Fever/drug therapy , Immunoglobulins, Intravenous/therapeutic use , Lymphadenitis/diagnosis , Lymphadenitis/drug therapy , Mucocutaneous Lymph Node Syndrome/complications , Mucocutaneous Lymph Node Syndrome/drug therapy
3.
Indian J Pathol Microbiol ; 2012 Apr-Jun 55(2): 202-205
Article in English | IMSEAR | ID: sea-142222

ABSTRACT

Background : The World Health Organization (WHO) has recommended Bacillus Calmette-Guerin (BCG) vaccination as a part of the global expanded program for immunization. Although the BCG vaccine is usually a safe vaccine, a number of complications with lymphadenitis being the most common complication, can occur. Aim : We evaluated the frequency, the clinical presentation and treatment modalities of lymphadenitis after BCG vaccine in Saudi children. Results : A total of 145 patients with BCG lymphadenitis presented between January 2005 and December 2010. In the majority (103) of the cases, the lymphadenitis involved ipsilateral left axillary nodes. Other sites of involvement included the left supraclavicular lymph nodes in 26 (18%) patients, and both the left axillary and supraclavicular lymph nodes were involved in 7 cases (4.8%). A total of 75 patients (65%) were given antituberculous medication. Eight (27%) patients had positive acid-fast bacilli and positive cultures for Mycobacterium bovis. Conclusion : In light of the findings of this study, it would be advisable to administer the BCG vaccine in Saudi Arabia at a time later than at birth, as the younger children are commonly affected.


Subject(s)
Age Factors , Antitubercular Agents/therapeutic use , BCG Vaccine/adverse effects , Drug-Related Side Effects and Adverse Reactions/drug therapy , Drug-Related Side Effects and Adverse Reactions/epidemiology , Drug-Related Side Effects and Adverse Reactions/pathology , Hospitals , Humans , Infant , Lymphadenitis/drug therapy , Lymphadenitis/epidemiology , Lymphadenitis/microbiology , Lymphadenitis/pathology , Male , Mycobacterium bovis/isolation & purification , Prevalence , Saudi Arabia/epidemiology
4.
Rev. Inst. Med. Trop. Säo Paulo ; 49(4): 267-270, Jul.-Aug. 2007. ilus
Article in English | LILACS | ID: lil-460238

ABSTRACT

Immune reconstitution inflammatory syndrome (IRIS) is an atypical and unexpected reaction related to highly active antiretroviral therapy (HAART) in human immunodeficiency virus (HIV) infected patients. IRIS includes an atypical response to an opportunistic pathogen (generally Mycobacterium tuberculosis, Mycobacterium avium complex, cytomegalovirus and herpes varicella-zoster), in patients responding to HAART with a reduction of plasma viral load and evidence of immune restoration based on increase of CD4+ T-cell count. We reported a case of a patient with AIDS which, after a first failure of HAART, developed a subcutaneous abscess and supraclavicular lymphadenitis as an expression of IRIS due to Mycobacterium avium complex after starting a second scheme of HAART.


El síndrome inflamatorio de reconstitución inmune (SIRI) es una reacción atípica e inesperada relacionada con el tratamiento antirretroviral de gran actividad (TARGA) en pacientes infectados por el virus de la inmunodeficiencia humana (VIH). El SIRI representa una respuesta inflamatoria frente a un patógeno oportunista (generalmente Mycobacterium tuberculosis, Complejo Mycobacterium avium, citomegalovirus y herpes varicela-zóster) en pacientes que responden a la TARGA con una marcada reducción de la carga viral en plasma y evidencia de una recuperación inmunológica expresada por el incremento de los niveles de linfocitos T CD4+. Presentamos el caso de un paciente con síndrome de inmunodeficiencia adquirida que desarrolló un absceso subcutáneo en muslo derecho y una adenitis supraclavicular izquierda como manifestación de SIRI por Complejo Mycobacterium avium luego del inicio de un segundo esquema de TARGA.


Subject(s)
Adult , Humans , Male , AIDS-Related Opportunistic Infections/etiology , Abscess/microbiology , Antiretroviral Therapy, Highly Active/adverse effects , Lymphadenitis/microbiology , Mycobacterium avium-intracellulare Infection/etiology , Systemic Inflammatory Response Syndrome/etiology , AIDS-Related Opportunistic Infections/drug therapy , AIDS-Related Opportunistic Infections/immunology , Abscess/drug therapy , Abscess/immunology , Lymphadenitis/drug therapy , Lymphadenitis/immunology , Mycobacterium avium-intracellulare Infection/drug therapy , Mycobacterium avium-intracellulare Infection/immunology , Systemic Inflammatory Response Syndrome/drug therapy , Systemic Inflammatory Response Syndrome/immunology , Viral Load
5.
Rev. chil. pediatr ; 76(4): 389-392, ago. 2005. ilus
Article in Spanish | LILACS | ID: lil-433006

ABSTRACT

Objetivo: Comunicar el caso de un adenoflegmón cervical por Streptococcus intermedius y caracterizar aspectos clínicos y microbiológicos de la infección por esta bacteria. Caso: Niña de 3 años, con historia de fiebre y aumento de volumen cervical anterior y supraclavicular izquierdo de 5 días de evolución, diagnosticándose adenoflegmón cervical; la punción revela Streptococcus intermedius. Se trató con cloxacilina y luego penicilina EV y completó tratamiento de 10 días con cotrimoxazol. Discusión: Streptococcus intermedius corresponde a una de las tres especies del grupo “anginosus” o “milleri”, integrante a su vez del grupo viridans. Forma parte de la flora bacteriana habitual orofaringea, de tubo digestivo y vagina. Tiene capacidad de migrar a otros parénquimas, produciendo infecciones abscedantes, a veces polimicrobianas y de difícil erradicación. Estudios nacionales de susceptibilidad antimicrobiana reportan sensibilidades cercanas al 100 por ciento a Penicilina y Cefotaxima. Diversos protocolos microbiológicos de identificación rápida permiten su diferenciación bacteriológica, ayudando a establecer alternativas terapéuticas más adecuadas.


Subject(s)
Humans , Female , Child, Preschool , Cellulite/microbiology , Neck/microbiology , Streptococcal Infections/complications , Streptococcal Infections/drug therapy , Lymphadenitis/microbiology , Streptococcus intermedius/isolation & purification , Cellulite/drug therapy , Cloxacillin/therapeutic use , Lymphadenitis/drug therapy , Penicillins/therapeutic use , Streptococcus milleri Group , Treatment Outcome
6.
Rev. chil. infectol ; 21(3): 229-231, 2004.
Article in Spanish | LILACS | ID: lil-383271

ABSTRACT

Se reporta el primer caso cubano de micobacteriosis causada por Mycobacterium malmoense en un paciente infectado por el virus de inmunodeficiencia humana (VIH), el cual presentaba adenopatías ulcerativas submandibulares. A partir de las muestras tomadas de las lesiones ulceradas, se aisló una cepa de micobacteria no pigmentada de crecimiento lento, perteneciente al grupo I de Runyon, posteriormente fue clasificada por test bioquímico y por el análisis de las fracciones de ácidos micólicos, como Mycobacterium malmoense.


Subject(s)
Humans , Male , Adult , HIV Infections , Lymphadenitis/etiology , Lymphadenitis/drug therapy , Mycobacterium Infections, Nontuberculous/complications , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium Infections, Nontuberculous/etiology , Mycolic Acids/analysis , Cuba , Patient Care
7.
J Indian Med Assoc ; 2003 Jan; 101(1): 16-7, 23
Article in English | IMSEAR | ID: sea-102134

ABSTRACT

Treatment of tuberculous (TB) lymphadenitis is virtually a specialist's job due to multiple aetiopathological factors. Diagnosis is difficult often requiring biopsy for several times. Treatment monitoring is more complex due to peculiar behaviour of TB lymph nodes. Situation has become worse due to sharp increase in the incidence of atypical mycobacteria. Due to profound improvement in antibiotic action, life-expectancy of immuno-compromised patients has also increased along with increased incidence of atypical mycobacteria in them. Clarithromycin, ethambutol, rifabutin and amikacin seem to act best on atypical mycobacteria-induced lymphadenitis. Along with rise of multi-drug resistance (MDR), drug-resistant TB lymphadenitis cases are also on the rise.


Subject(s)
Antitubercular Agents/therapeutic use , Drug Therapy, Combination , Humans , Lymphadenitis/drug therapy , Mycobacterium Infections, Nontuberculous/drug therapy , Tuberculosis, Lymph Node/drug therapy , Tuberculosis, Multidrug-Resistant/drug therapy
8.
Southeast Asian J Trop Med Public Health ; 1995 Jun; 26(2): 301-5
Article in English | IMSEAR | ID: sea-32085

ABSTRACT

Episodic adenolymphangitis (ADL) is one of the important clinical manifestations of lymphatic filariasis. Recurrent ADLs contribute to the progress of the disease and also have important socioeconomic implications since they cause significant loss of man days. The present study was conducted in order to identify the precipitating factors responsible for ADL attacks and also to examine the different modalities of treatment. Sixty-five individuals with filariasis related ADL attacks, who are residents of Alleppey district (endemic for Brugia malayi) were studied. All efforts were taken to identify the precipitating factors for ADLs in these individuals. They were hospitalized for a period of five days or more. All of them received symptomatic antipyretic/antiinflammatory therapy and topical antibiotic/antifungal treatment of the affected limbs. They were then randomly allocated to one of the following four regimens: group I - symptomatic alone; group II - symptomatic plus antibiotics; group III - symptomatic followed by diethylcarbamazine citrate (DEC) and group IV - symptomatic plus antibiotic followed by DEC. Patients in groups III and IV received DEC every three months up to one year. There was a significant relationship between the number of ADL attacks and the grade of edema. Presence of focus of infection in the affected limb could be identified in 28 of the 65 patients. In the majority of patients (48) response to treatment was rapid (resolution in less than five days). Neither antibiotics nor DEC (given at intervals of three months) appeared to alter the frequency of ADL attacks. On the otherhand simple hygienic measures combined with good foot care and local antibiotic/antifungal cream application (where required), were effective in reducing the number of ADL attacks.


Subject(s)
Adolescent , Adult , Aged , Animals , Anti-Bacterial Agents/therapeutic use , Brugia , Causality , Diethylcarbamazine/therapeutic use , Elephantiasis, Filarial/complications , Female , Filaricides/therapeutic use , Health Education , Humans , India/epidemiology , Lymphadenitis/drug therapy , Lymphangitis/drug therapy , Lymphedema/parasitology , Male , Middle Aged , Recurrence , Socioeconomic Factors
9.
Southeast Asian J Trop Med Public Health ; 1989 Jun; 20(2): 183-7
Article in English | IMSEAR | ID: sea-30682

ABSTRACT

Serum IgG levels and complement C3 levels were assayed on Day 0, 1, 3-4, 7 and 56-70 post-treatment with diethylcarbamizine citrate (DEC) in a series to 26 patients with Brugia malayi infection and 6 volunteers without infection. On treatment, the microfilariae were cleared from the blood within 24 hours. The eosinophils decreased dramatically on Day 1 post-treatment but increased rapidly by Day 4 to 7 and then dropped to normal levels in 45 days. The serum IgG mean levels decreased briefly following treatment with DEC but then returned to original levels. However, the complement C3 levels gradually increased over the 2 months period of study reaching statistical significance levels (p less than 0.01) in patients with initial high blood microfilariae. The observation suggests that Brugia malayi infection probably induces a high rate of synthesis of complement C3 and this process continued in the post-treatment phase. Since, DEC treatment did not cause a decrease in complement C3 with the elimination of blood microfilariae, it would appear that the complement C3 is consumed following antibody attachment to the microfilariae as they enter the blood circulation.


Subject(s)
Adult , Animals , Anthelmintics/therapeutic use , Brugia , Complement C3/analysis , Elephantiasis, Filarial/blood , Filariasis/drug therapy , Filaricides/therapeutic use , Humans , Lymphadenitis/drug therapy , Lymphangitis/drug therapy
10.
SELECTION OF CITATIONS
SEARCH DETAIL